GARAJOVA, INGRID
GARAJOVA, INGRID
CENTRO INTERDIPARTIMENTALE ALMA MATER INSTITUTE ON HEALTHY PLANET
Assegnisti
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary
2024 Cavazzoni A.; Salamon I.; Fumarola C.; Gallerani G.; Laprovitera N.; Gelsomino F.; Riefolo M.; Rihawi K.; Porcellini E.; Rossi T.; Mazzeschi M.; Naddeo M.; Serravalle S.; Broseghini E.; Agostinis F.; Deas O.; Roncarati R.; Durante G.; Pace I.; Lauriola M.; Garajova I.; Calin G.A.; Bonafe M.; D'Errico A.; Petronini P.G.; Cairo S.; Ardizzoni A.; Sales G.; Ferracin M.
Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis
2023 Garajova I.; Gelsomino F.; Salati M.; Leonardi F.; De Lorenzo S.; Granito A.; Tovoli F.
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv)
2023 Giulia Orsi, Alessandro Cavaliere, Giampaolo Tortora, Sara Lonardi , Marina Macchini, Mariacristina Di Marco, Guido Giordano, Enrico Vasile, Mario Scartozzi, Silvia Bozzarelli, Silvia Noventa, Maria Grazia Rodriquenz, Anna Maria Militello, Ilario Giovanni Rapposelli, Ingrid Garajova, Stefania De Lorenzo, Barbara Merelli, Alessandro Bittoni, Lisa Salvatore, Letizia Procaccio, Chiara Paratore, Andrea Spallanzani, Umberto Peretti, Monica Niger, Elisa Giommoni, Ilaria Bernardini, Emiliano Tamburini, Katia Bernardino, Laura Forti, Maria Maddalena Valente, Stefano Cascinu, Michele Milella and Michele Reni
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?
2022 Antonetti, Paolo; Fargnoli, Maria Concetta; Porzio, Giampiero; Salvatore, Lisa; Filippi, Roberto; Ghidini, Michele; Nigro, Olga; Gelsomino, Fabio; Zurlo, Ina Valeria; Dell’Aquila, Emanuela; Lombardi, Pasquale; Keränen, Susana Roselló; Depetris, Ilaria; Giampieri, Riccardo; Morelli, Cristina; De Tursi, Michele; Di Pietro, Francesca Romana; Zanaletti, Nicoletta; Vitale, Pasquale; Garajova, Ingrid; Spinelli, Gian Paolo; Zoratto, Federica; Roberto, Michela; Petrillo, Angelica; Aimar, Giacomo; Cortellini, Alessio; Pensieri, Maria Vittoria; Ficorella, Corrado; Ferri, Claudio; Parisi, Alessandro
Should patients on levothyroxine therapy be screened for pancreatic cancer?
2022 Garajova I.; Balsano R.; Coriano' M.; Gelsomino F.; Tovoli F.; De Lorenzo S.; Del Rio P.; Valle R.D.; Ravaioli M.; Leonardi F.
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey
2021 Orsi G.; Di Marco M.; Cavaliere A.; Niger M.; Bozzarelli S.; Giordano G.; Noventa S.; Rapposelli I.G.; Garajova I.; Tortora G.; Rodriquenz M.G.; Bittoni A.; Penzo E.; De Lorenzo S.; Peretti U.; Paratore C.; Bernardini I.; Mosconi S.; Spallanzani A.; Macchini M.; Tamburini E.; Bencardino K.; Giommoni E.; Scartozzi M.; Forti L.; Valente M.M.; Militello A.M.; Cascinu S.; Milella M.; Reni M.
Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second-line clinical trials
2021 Tovoli F.; Garajova I.; Gelsomino F.; Iavarone M.; Federico P.; Salati M.; Coriano M.; Caputo F.; De Lorenzo S.; Granito A.; Renzulli M.; Daniele B.; Piscaglia F.
Synchronous and metachronous colorectal liver metastases: Impact of primary tumor location on patterns of recurrence and survival after hepatic resection
2021 Garajova I.; Balsano R.; Tommasi C.; Valle R.D.; Pedrazzi G.; Ravaioli M.; Spallanzani A.; Leonardi F.; Santini C.; Caputo F.; Riefolo M.; Giuffrida M.; Gelsomino F.
Targeted therapies for gallbladder cancer: an overview of agents in preclinical and clinical development
2021 De Lorenzo S.; Garajova I.; Stefanini B.; Tovoli F.
Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments
2019 Tavolari S; Deserti M; Vasuri F; Curti S; Palloni A; Pinna AD; Cescon M; Frega G; De Lorenzo S; Barbera MA; Garajova I; Ricciardiello L; Malvi D; D'Errico-Grigioni A; Pantaleo MA; Brandi G
Brain Metastases from Biliary Tract Cancer: A Monocentric Retrospective Analysis of 450 Patients
2018 Frega, Giorgio; Garajová, Ingrid; Palloni, Andrea; Barbera, Maria Aurelia; Trossello Pastore, Marco; Faccioli, Luca; Spinardi, Luca; De Lorenzo, Stefania; Cubelli, Marta; Pantaleo, Maria Abbondanza; Biasco, Guido; Brandi, Giovanni*
Epigenetic and epitranscriptomic changes in colorectal cancer: diagnostic, prognostic, and treatment implications
2018 Porcellini, Elisa; Laprovitera, Noemi; Riefolo, Mattia; Ravaioli, Matteo; Garajova, Ingrid; Ferracin, Manuela
Heterotopic auxiliary segment 2–3 liver transplantation with delayed total hepatectomy: New strategies for nonresectable colorectal liver metastases
2018 Ravaioli, Matteo*; Fallani, Guido; Cescon, Matteo; Prosperi, Enrico; De Pace, Vanessa; Siniscalchi, Antonio; Sangiorgi, Gabriela; Ferracin, Manuela; Ardizzoni, Andrea; Morelli, Maria Cristina; Garajová, Ingrid
Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: A proof of concept
2018 De Lorenzo, Stefania; Tovoli, Francesco; Barbera, Maria Aurelia; Garuti, Francesca; Palloni, Andrea; Frega, Giorgio; Garajovà, Ingrid; Rizzo, Alessandro; Trevisani, Franco; Brandi, Giovanni
SUSTAINED COMPLETE RESPONSE OF ADVANCED HEPATOCELLULAR CARCINOMA WITH METRONOMIC CAPECITABINE: A REPORT OF THREE CASES
2018 Brandi, Giovanni*; Venturi, Michela; De Lorenzo, Stefania; Garuti, Francesca; Frega, Giorgio; Palloni, Andrea; Garajovà, Ingrid; Abbati, Francesca; Saccoccio, Gioconda; Golfieri, Rita; Pantaleo, Maria Abbondanza; Barbera, Maria Aurelia
Circulating microRNAs as dynamic biomarkers of response to treatment with FOLFIRINOX combination therapy in advanced pancreatic ductal adenocarcinoma
2017 Meijer, LL; Frampton, AE; Garajova, I; Caparello, C; Le Large, TYS; Funel, N; Vasile, E; Stebbing, J; Krell, J; Kazemier, G; Giovannetti, E
Oxaliplatin in pre-treated patients: Maybe not the match point?
2017 Caparello, Chiara; Vasile, Enrico; Garajova, Ingrid; Ali, Asif; Giovannetti, Elisa
Postsorafenib systemic treatments for hepatocellular carcinoma: Questions and opportunities after the regorafenib trial
2017 Tovoli, Francesco; De Lorenzo, Stefania; Barbera, Maria Aurelia; Garajova, Ingrid; Frega, Giorgio; Palloni, Andrea; Pantaleo, Maria Abbondanza; Biasco, Guido; Brandi, Giovanni
Circulating micrornas as dynamic biomarkers of disease progression during folfirinox therapy in unresectable pancreatic ductal adenocarcinoma (pdac)
2016 Meijer, L.L.; Garajová, I.; Caparello, C.; Le Large, T.Y.S.; Funel, N.; Vasile, E.; Giovannetti, E.; Zonderhuis, B.M.; Daams, F.; Kazemier, G.
D32Left versus right side primary tumor: the correlation with clinical outcome of patients with resected stage II and III colorectal cancer
2016 Palloni, A.; Barbera, M.A.; Frega, G.; Abbati, F.; Biasco, G.; Garajova, I.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary | Cavazzoni A.; Salamon I.; Fumarola C.; Gallerani G.; Laprovitera N.; Gelsomino F.; Riefolo M.; Ri...hawi K.; Porcellini E.; Rossi T.; Mazzeschi M.; Naddeo M.; Serravalle S.; Broseghini E.; Agostinis F.; Deas O.; Roncarati R.; Durante G.; Pace I.; Lauriola M.; Garajova I.; Calin G.A.; Bonafe M.; D'Errico A.; Petronini P.G.; Cairo S.; Ardizzoni A.; Sales G.; Ferracin M. | 2024-01-01 | MOLECULAR THERAPY | - | 1.01 Articolo in rivista | 2024_MolTher_CUP-models.pdf; ScienceDirect_files_14-10-27.154.zip |
| Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis | Garajova I.; Gelsomino F.; Salati M.; Leonardi F.; De Lorenzo S.; Granito A.; Tovoli F. | 2023-01-01 | CURRENT ONCOLOGY | - | 1.01 Articolo in rivista | curroncol-30-00199.pdf |
| Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv) |
Giulia Orsi, Alessandro Cavaliere, Giampaolo Tortora, Sara Lonardi , Marina Macchini, Mariacrist...ina Di Marco, Guido Giordano, Enrico Vasile, Mario Scartozzi, Silvia Bozzarelli, Silvia Noventa, Maria Grazia Rodriquenz, Anna Maria Militello, Ilario Giovanni Rapposelli, Ingrid Garajova, Stefania De Lorenzo, Barbara Merelli, Alessandro Bittoni, Lisa Salvatore, Letizia Procaccio, Chiara Paratore, Andrea Spallanzani, Umberto Peretti, Monica Niger, Elisa Giommoni, Ilaria Bernardini, Emiliano Tamburini, Katia Bernardino, Laura Forti, Maria Maddalena Valente, Stefano Cascinu, Michele Milella and Michele Reni |
2023-01-01 | BRITISH JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement? | Antonetti, Paolo; Fargnoli, Maria Concetta; Porzio, Giampiero; Salvatore, Lisa; Filippi, Roberto;... Ghidini, Michele; Nigro, Olga; Gelsomino, Fabio; Zurlo, Ina Valeria; Dell’Aquila, Emanuela; Lombardi, Pasquale; Keränen, Susana Roselló; Depetris, Ilaria; Giampieri, Riccardo; Morelli, Cristina; De Tursi, Michele; Di Pietro, Francesca Romana; Zanaletti, Nicoletta; Vitale, Pasquale; Garajova, Ingrid; Spinelli, Gian Paolo; Zoratto, Federica; Roberto, Michela; Petrillo, Angelica; Aimar, Giacomo; Cortellini, Alessio; Pensieri, Maria Vittoria; Ficorella, Corrado; Ferri, Claudio; Parisi, Alessandro | 2022-01-01 | SUPPORTIVE CARE IN CANCER | - | 1.01 Articolo in rivista | - |
| Should patients on levothyroxine therapy be screened for pancreatic cancer? | Garajova I.; Balsano R.; Coriano' M.; Gelsomino F.; Tovoli F.; De Lorenzo S.; Del Rio P.; Valle R....D.; Ravaioli M.; Leonardi F. | 2022-01-01 | ACTA BIO-MEDICA DE L'ATENEO PARMENSE | - | 1.01 Articolo in rivista | ACTA-93-268.pdf |
| Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey | Orsi G.; Di Marco M.; Cavaliere A.; Niger M.; Bozzarelli S.; Giordano G.; Noventa S.; Rapposelli ...I.G.; Garajova I.; Tortora G.; Rodriquenz M.G.; Bittoni A.; Penzo E.; De Lorenzo S.; Peretti U.; Paratore C.; Bernardini I.; Mosconi S.; Spallanzani A.; Macchini M.; Tamburini E.; Bencardino K.; Giommoni E.; Scartozzi M.; Forti L.; Valente M.M.; Militello A.M.; Cascinu S.; Milella M.; Reni M. | 2021-01-01 | ESMO OPEN | - | 1.01 Articolo in rivista | articolo 2021 Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv)- a multicenter survey.pdf |
| Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second-line clinical trials | Tovoli F.; Garajova I.; Gelsomino F.; Iavarone M.; Federico P.; Salati M.; Coriano M.; Caputo F.;... De Lorenzo S.; Granito A.; Renzulli M.; Daniele B.; Piscaglia F. | 2021-01-01 | LIVER INTERNATIONAL | - | 1.01 Articolo in rivista | Liver International - 2021 - Tovoli - Pattern of progression of intrahepatic cholangiocarcinoma Implications for (1).pdf; liv15117-sup-0001-tables1.docx; liv15117-sup-0002-tables2.docx |
| Synchronous and metachronous colorectal liver metastases: Impact of primary tumor location on patterns of recurrence and survival after hepatic resection | Garajova I.; Balsano R.; Tommasi C.; Valle R.D.; Pedrazzi G.; Ravaioli M.; Spallanzani A.; Leonar...di F.; Santini C.; Caputo F.; Riefolo M.; Giuffrida M.; Gelsomino F. | 2021-01-01 | ACTA BIO-MEDICA DE L'ATENEO PARMENSE | - | 1.01 Articolo in rivista | - |
| Targeted therapies for gallbladder cancer: an overview of agents in preclinical and clinical development | De Lorenzo S.; Garajova I.; Stefanini B.; Tovoli F. | 2021-01-01 | EXPERT OPINION ON INVESTIGATIONAL DRUGS | - | 1.01 Articolo in rivista | - |
| Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments | Tavolari S; Deserti M; Vasuri F; Curti S; Palloni A; Pinna AD; Cescon M; Frega G; De Lorenzo S; B...arbera MA; Garajova I; Ricciardiello L; Malvi D; D'Errico-Grigioni A; Pantaleo MA; Brandi G | 2019-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.01 Articolo in rivista | 1-s2.0-S0959804918314667-main.pdf |
| Brain Metastases from Biliary Tract Cancer: A Monocentric Retrospective Analysis of 450 Patients | Frega, Giorgio; Garajová, Ingrid; Palloni, Andrea; Barbera, Maria Aurelia; Trossello Pastore, Mar...co; Faccioli, Luca; Spinardi, Luca; De Lorenzo, Stefania; Cubelli, Marta; Pantaleo, Maria Abbondanza; Biasco, Guido; Brandi, Giovanni* | 2018-01-01 | ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Epigenetic and epitranscriptomic changes in colorectal cancer: diagnostic, prognostic, and treatment implications | Porcellini, Elisa; Laprovitera, Noemi; Riefolo, Mattia; Ravaioli, Matteo; Garajova, Ingrid; Ferra...cin, Manuela | 2018-01-01 | CANCER LETTERS | - | 1.01 Articolo in rivista | - |
| Heterotopic auxiliary segment 2–3 liver transplantation with delayed total hepatectomy: New strategies for nonresectable colorectal liver metastases | Ravaioli, Matteo*; Fallani, Guido; Cescon, Matteo; Prosperi, Enrico; De Pace, Vanessa; Siniscalch...i, Antonio; Sangiorgi, Gabriela; Ferracin, Manuela; Ardizzoni, Andrea; Morelli, Maria Cristina; Garajová, Ingrid | 2018-01-01 | SURGERY | - | 1.01 Articolo in rivista | - |
| Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: A proof of concept | De Lorenzo, Stefania; Tovoli, Francesco; Barbera, Maria Aurelia; Garuti, Francesca; Palloni, Andr...ea; Frega, Giorgio; Garajovà, Ingrid; Rizzo, Alessandro; Trevisani, Franco; Brandi, Giovanni | 2018-01-01 | SCIENTIFIC REPORTS | - | 1.01 Articolo in rivista | 45.Cape ChildB.pdf |
| SUSTAINED COMPLETE RESPONSE OF ADVANCED HEPATOCELLULAR CARCINOMA WITH METRONOMIC CAPECITABINE: A REPORT OF THREE CASES | Brandi, Giovanni*; Venturi, Michela; De Lorenzo, Stefania; Garuti, Francesca; Frega, Giorgio; Pal...loni, Andrea; Garajovà, Ingrid; Abbati, Francesca; Saccoccio, Gioconda; Golfieri, Rita; Pantaleo, Maria Abbondanza; Barbera, Maria Aurelia | 2018-01-01 | CANCER COMMUNICATIONS | - | 1.01 Articolo in rivista | 5.40880_2018_Article_312.pdf |
| Circulating microRNAs as dynamic biomarkers of response to treatment with FOLFIRINOX combination therapy in advanced pancreatic ductal adenocarcinoma | Meijer, LL; Frampton, AE; Garajova, I; Caparello, C; Le Large, TYS; Funel, N; Vasile, E; Stebbing..., J; Krell, J; Kazemier, G; Giovannetti, E | 2017-01-01 | THE LANCET | - | 4.02 Riassunto (Abstract) | - |
| Oxaliplatin in pre-treated patients: Maybe not the match point? | Caparello, Chiara; Vasile, Enrico; Garajova, Ingrid; Ali, Asif; Giovannetti, Elisa | 2017-01-01 | TRANSLATIONAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Postsorafenib systemic treatments for hepatocellular carcinoma: Questions and opportunities after the regorafenib trial | Tovoli, Francesco; De Lorenzo, Stefania; Barbera, Maria Aurelia; Garajova, Ingrid; Frega, Giorgio...; Palloni, Andrea; Pantaleo, Maria Abbondanza; Biasco, Guido; Brandi, Giovanni | 2017-01-01 | FUTURE ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Circulating micrornas as dynamic biomarkers of disease progression during folfirinox therapy in unresectable pancreatic ductal adenocarcinoma (pdac) | Meijer, L.L.; Garajová, I.; Caparello, C.; Le Large, T.Y.S.; Funel, N.; Vasile, E.; Giovannetti, ...E.; Zonderhuis, B.M.; Daams, F.; Kazemier, G. | 2016-01-01 | HPB | - | 4.03 Poster | - |
| D32Left versus right side primary tumor: the correlation with clinical outcome of patients with resected stage II and III colorectal cancer | Palloni, A.; Barbera, M.A.; Frega, G.; Abbati, F.; Biasco, G.; Garajova, I. | 2016-01-01 | ANNALS OF ONCOLOGY | - | 4.03 Poster | - |